Table 1.

Characteristics of the control and case samples in Systematic Coronary Risk Evaluation (SCORE)—A; Framingham Risk Score for Coronary Heart Disease (FRS_CHD) and Framingham Risk Score for Cardiovascular Disease (FRS_CVD) algorithm analyses—B.

A	Control (n = 52)	Case (n = 124)	p -Value
	Average (Std. Dev.)
Age (years)	51.23 (0.90)	49.66 (0.59)	0.164
BMI (kg/m2)	25.14 (0.77)	29.29 (0.55)	<0.001 *
Systolic blood pressure (mmHg)	130.10 (2.40)	127.15 (1.46)	0.214
Fasting glucose (mmol/L)	5.55 (0.29)	5.47 (0.15)	0.844
Total cholesterol (mmol/L)	4.59 (0.09)	5.05 (0.10)	0.004 *
Triacylglycerol (mmol/L)	0.97 (0.04)	2.08 (0.10)	<0.001 *
High-density lipoprotein Cholesterol (mmol/L)	1.62 (0.05)	1.01 (0.02)	<0.001 *
	Prevalence in % (95%CI)		p-value
Roma	50.00 (36.72–63.28)	54.03 (45.25–62.63)	0.625
Women	48.08 (34.91–61.45)	75.81 (67.73–82.69)	<0.001 *
Current smoker	49.02 (35.67–62.48)	55.28 (46.46–63.86)	0.451
Treated for high blood pressure	28.85 (17.92–42.05)	36.29 (28.22–44.99)	0.342
Treated for diabetes	11.54 (4.96–22.24)	10.48 (6.01–16.78)	0.837
B	Control (n = 64)	Case (n = 191)	p -Value
	Average (Std. Dev.)
Age (years)	48.12 (1.10)	44.29 (0.67)	0.004 *
BMI (kg/m2)	24.78 (0.67)	29.07 (0.45)	<0.001 *
Systolic blood pressure (mmHg)	128.57 (2.08)	124.59 (1.14)	0.049 *
Fasting glucose (mmol/L)	5.28 (0.25)	5.26 (0.11)	0.950
Total cholesterol (mmol/L)	4.55 (0.08)	4.91 (0.08)	0.013 *
Triacylglycerol (mmol/L)	0.94 (0.04)	2.04 (0.08)	<0.001 *
High-density lipoprotein cholesterol (mmol/L)	1.63 (0.05)	1.01 (0.01)	<0.001 *
	Prevalence in % (95%CI)		p-value
Roma	50.00 (37.98–62.02)	45.03 (38.09–52.11)	0.490
Women	48.44 (36.49–60.52)	72.77 (66.15–78.71)	<0.001 *
Current smoker	49.21 (37.13–61.35)	56.84 (49.74–63.74)	0.291
Treated for high blood pressure	25.00 (15.65–36.55)	30.89 (24.66–37.69)	0.371
Treated for diabetes	9.38 (4.01–18.30)	7.85 (4.66–12.31)	0.702

*: p < 0.05.